Charles River Laboratories vs Lonza: CDMO Comparison
Side-by-side comparison of Charles River Laboratories and Lonza on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score
92/100
Quality (FDA + GMP)
99/100
FDA inspections
7
— NAI / VAI / OAI
4 / 3 / 0
FDA warning letters
0
EMA GMP certificates (active)
9
MHRA GMP certificates (compliant)
2
Clinical programs (matched)
0
Capacity
Limited
Modalities
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
Lonza →
78.2
Basel, Switzerland
Signal Score
78/100
Quality (FDA + GMP)
95/100
FDA inspections
2
— NAI / VAI / OAI
0 / 2 / 0
FDA warning letters
0
EMA GMP certificates (active)
3
MHRA GMP certificates (compliant)
5
Clinical programs (matched)
1
Capacity
—
Modalities
AAV, Lentiviral, Cell Therapy, mRNA
Evaluating Charles River Laboratories and Lonza for a program?
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.